- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 3B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$7.1M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$14.79M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.26M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $29.02M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $11.39M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $46.74M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $54.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $53.51M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $55.44M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.97M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $11.59M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $14.92M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $15.24M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $42.79M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $48.86M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $61.66M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $69.26M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.19M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.81M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $566K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $583K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7.58M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$10.26M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$7.63M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$10.74M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$3.35M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.91M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.12M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.56M |
| Revenue | Q1 2026 · Mar 31, 2025 | $123K |
| Capex | Q1 2026 · Mar 31, 2025 | $100K |